394 related articles for article (PubMed ID: 27592541)
1. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
[TBL] [Abstract][Full Text] [Related]
3. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.
Schiffman SC; McMasters KM; Scoggins CR; Martin RC; Chagpar AB
J Am Coll Surg; 2011 Jul; 213(1):45-52; discussion 52-3. PubMed ID: 21601490
[TBL] [Abstract][Full Text] [Related]
5. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
6. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
Zheng Y; Chen Q; Liang Z; Jia M; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
[TBL] [Abstract][Full Text] [Related]
8. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
9. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.
Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A
Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
[TBL] [Abstract][Full Text] [Related]
11. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
[TBL] [Abstract][Full Text] [Related]
12. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
Giuliante F; Ardito F; Guglielmi A; Aldrighetti L; Ferrero A; Calise F; Giulini SM; Jovine E; Breccia C; De Rose AM; Pinna AD; Nuzzo G
JAMA Surg; 2016 Oct; 151(10):916-922. PubMed ID: 27556741
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
[TBL] [Abstract][Full Text] [Related]
15. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
16. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
17. Lymph-Node Ratio in Patients with Cutaneous Melanoma: A Multi-Institution Prognostic Study.
Sandro P; Andrea M; Nicola M; Simone M; Giuseppe M; Lorenzo B; Nicola S; Dario P; Luigi M; Giuseppe G; Roberto P; Corrado C; Simone R; Ugo M; Mario S; Riccardo RC
Ann Surg Oncol; 2015 Jul; 22(7):2127-34. PubMed ID: 25316489
[TBL] [Abstract][Full Text] [Related]
18. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
19. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
[TBL] [Abstract][Full Text] [Related]
20. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma.
Grotz TE; Huebner M; Pockaj BA; Perkins S; Jakub JW
Ann Surg Oncol; 2013 Dec; 20(13):4370-7. PubMed ID: 24046102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
